PrecisionLife will be presenting Precision Medicine for Alzheimer's Disease at the UK’s largest dementia research event, the Alzheimer’s Research UK Conference.
Krystyna Taylor, Senior Portfolio Manager and Andy Malinowski, Senior Disease Biologist will present research that is helping to identify effective therapeutic strategies in Alzheimer's disease and enabling clinical trials to have greater probability of success using mechanistic biomarkers to stratify Alzheimer's patients into subgroups who are more likely to respond to a specific therapy.
Presentation details
Number: 1.78
Theme: Alzheimer Disease
Title: Precision Medicine for Alzheimer’s Disease - Identifying Effective Therapeutic Strategies and Enriching Clinical Trials with Patient Stratification Biomarkers
To see the agenda and register, visit the ARUK Conference website.
Understanding disease mechanisms to identify novel targets matched to mechanistic patient stratification biomarkers to inform and derisk drug discovery and development in Alzheimer's disease.